ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

New Therapeutic Modalities In Testing For Patients With Carcinoid Syndrome

November 28, 2003

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

August 27, 2010

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995